**Education and Professional Experience:** 1997.09-2002.06 Bachelor of Clinical Medicine, Peking University Health Science Center 2002.07-2010.12 Combined Master's and Doctoral Program, Department of Breast Surgery, The First Affiliated Hospital, Sun Yat-sen University 2005.07-2010.06 Visiting Scholar, Cancer Center, University of Michigan Medical School, USA 2011.07-2014.12 Resident Physician, Department of Oncology, The First Affiliated Hospital, Sun Yat-sen University 2015.01-2016.12 Attending Physician, Department of Oncology, The First Affiliated Hospital, Sun Yat-sen University 2017.01-Present Associate Chief Physician, Department of Oncology, The First Affiliated Hospital, Sun Yat-sen University **Professional Affiliations:** Executive Deputy Director, Center for Cellular Immunotherapy; Member, Committee of Clinical Chemotherapy, Chinese Anti-Cancer Association; Standing Committee Member, Oncology Branch, Guangdong Medical Association; Vice Chair, Pancreatic Disease Committee, Guangdong Health Management Association; Standing Committee Member, Breast Disease Committee, Guangdong Health Management Association. **Publications:** Principal Investigator of 2 National Natural Science Foundation of China (NSFC) projects, 2 Natural Science Foundation of Guangdong Province projects, and 1 Guangzhou Science and Technology Plan project. Published over 20 SCI-indexed papers as first author or corresponding author, with a highest single-article Impact Factor of 17. (1) Long J, Jiang C, Liu B, Dai Q, Hua R, Chen C, Zhang B, Li H. Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling. Cancer Lett. 2018; 423:113-26. (IF: 7.36) (2) Jiang C, Long J, Liu B, Xu M, Wang W, Xie X, Wang X, Kuang M. miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma. J Exp Clin Cancer Res. 2017; 36(1):99. (IF: 7.068) (3) Xie B, Liu Y, Zhao Z, Liu Q, Wang X, Xie Y, Liu Y, Liu Y, Yang Y, Long J, Dai Q, Li H. MYB Proto-oncogene-like 1-TWIST1 Axis Promotes Growth and Metastasis of Hepatocellular Carcinoma Cells. Mol Ther Oncolytics 2020 Sep 25;18. (IF: 4.115) (4) Long J, Parkin B, Ouillette P, Bixby D, Shedden K, Erba H, Wang S, Malek SN. Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia. Blood. 2010;116(1):71-80. (IF: 17.534) **Books:** Co-editor of a surgical teaching aid; Co-editor of the *Chinese Clinical Medication Manual*.